TrialClinical cardiology2014

Design and rationale of the GAUSS-2 study trial: a double-blind, ezetimibe-controlled phase 3 study of the efficacy and tolerability of evolocumab (AMG 145) in subjects with hypercholesterolemia who are intolerant of statin therapy.

Leslie Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.